论文信息 - Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone. - 字舞流文

Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone.

D. Coit | M. Suárez-Fariñas | J. Krueger | Nicholas Gulati | S. Garcet | J. Fuentes-Duculan | P. Gilleaudeau | M. Sullivan-Whalen | Xuan Li

[1] M. Suárez-Fariñas,et al. Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis , 2016, PloS one.

[2] Wei Zhou,et al. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. , 2015, The Lancet. Oncology.

[3] M. Suárez-Fariñas,et al. Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights , 2014, The Journal of investigative dermatology.

[4] R. Saw,et al. Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma , 2014, Journal of surgical oncology.